Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of hV01 in advanced sarcoma and recurrent or metastatic cervical cancer
CTR20244266Phase 2Active
- Sponsor
- Hangzhou ConVerd Co., Ltd.
- Start
- Apr 2025
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CVD-1301.V01 in Bone and soft tissue sarcoma, Cervical Cancer (CC), sponsored by Hangzhou ConVerd Co., Ltd.. Started Apr 2025; status: active.
02
Drugs
CVD-1301.V01
03
Conditions
Bone and soft tissue sarcomaCervical Cancer (CC)
Beyond the preview
Go deeper on CTR20244266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244266.